Gene · 1308
Papers3,031
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,031
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A rare case of keloid combined with bullous pemphigoid. | Dermatol Reports | 2026 | 41069272 | PubTator, text mining | PubMed |
| Clinical Predictors of Steroid Resistance in Moderate-to-Severe Bullous Pemphigoid Patients: A 15-Year Retrospective Study. | J Dermatol | 2026 | 41025370 | PubTator, text mining | PubMed |
| Estimating Ancestral States of Complex Characters: A Case Study on the Evolution of Feathers. | Syst Biol | 2026 | 40971608 | PubTator, text mining | PubMed |
| Effectiveness and safety of off-label dupilumab use for the treatment of pemphigoid gestationis: a new case report. | Eur J Hosp Pharm | 2026 | 40962480 | PubTator, text mining | PubMed |
| A novel variant c.A527G in ITGB4 leads to autosomal dominant epidermolysis bullosa in China. | Front Med (Lausanne) | 2025 | 41728014 | PubTator, text mining | PubMed |
| Omalizumab Therapy for Bullous Pemphigoid: A Case Report. | Cureus | 2025 | 41625830 | PubTator, text mining | PubMed |
| Genetic variations in extracellular matrix degradation pathways linking to major depressive disorder: Evidence from a large-scale genetic association study. | Biomedicine (Taipei) | 2025 | 41523645 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms, Assessment and Therapeutics of Epidermal Stem Cells in Skin Aging. | Stem Cells Int | 2025 | 41497803 | PubTator, text mining | PubMed |
| Bullous pemphigoid induced by anti-IL-23 monoclonal antibody in a psoriatic patient: a case report. | Front Med (Lausanne) | 2025 | 41488061 | PubTator, text mining | PubMed |
| From Skin to Brain: Key Genetic Mediators Associating Cutaneous Inflammation and Neurodegenerative Diseases. | Genes (Basel) | 2025 | 41465136 | PubTator, text mining | PubMed |
| Prognostic role of stress granule-related Gene signatures in pancreatic ductal adenocarcinoma: insights from 101-combination machine learning and single-cell sequencing. | Int J Surg | 2025 | 41403347 | PubTator, text mining | PubMed |
| PathoEye: A deep learning framework for the whole-slide image analysis of skin tissue. | Comput Struct Biotechnol J | 2025 | 41395109 | PubTator, text mining | PubMed |
| In Vitro Bioactivity of a Recombinant Human Collagen Peptide in a Filler Biomimetic Skin Model. | J Cosmet Dermatol | 2025 | 41384336 | PubTator, text mining | PubMed |
| A Rare Case of Bullous Pemphigoid Triggered by Overlapping Immune Dysregulation From HIV and Hodgkin Lymphoma: A Case Report. | Cureus | 2025 | 41328101 | PubTator, text mining | PubMed |
| Transforming growth factor alpha promotes bullous pemphigoid pathogenesis by disrupting cell adhesion and inducing inflammation. | Cell Mol Life Sci | 2025 | 41307670 | PubTator, text mining | PubMed |
| Bridging Decades in Cutaneous Immunology-Past Lessons, Present Insights, Future Directions. | Biomedicines | 2025 | 41301807 | PubTator, text mining | PubMed |
| Integrating machine learning and experimental validation identifies a post-translational modification gene signature for prognosis and treatment response in breast cancer. | Sci Rep | 2025 | 41238648 | PubTator, text mining | PubMed |
| Effect of Protease-Treated Royal Jelly Extract on Facial Wrinkles: A Placebo-Controlled, Double-Blind, Parallel-Group Study. | J Cosmet Dermatol | 2025 | 41134061 | PubTator, text mining | PubMed |
| Pemphigoid Antibodies in Patients with Oral Lichen Planus: A Systematic Review. | Pathophysiology | 2025 | 41133525 | PubTator, text mining | PubMed |
| Pain - related methylation driver genes affect the prognosis of pancreatic cancer patients by altering immune function and perineural infiltration. | Front Genet | 2025 | 41132793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1308/papers?page=6